Glucagon | CAS 16941-32-5

Product Details

CasNo： 16941-32-5

Molecular Formula： C153H225N43O49S

Appearance： White to off-white powder / lyophilized powder

Delivery Time： Confirmed according to quantity, specification, and project requirements

Packing： According to quantity and project requirements

Throughput： Project-based

Purity： ≥95%

Product Overview

Glucagon, CAS 16941-32-5, is a single-chain peptide hormone composed of 29 amino acids. It is a well-defined ligand in Glucagon Receptor (GCGR) research and is widely used in studies involving peptide–receptor interactions, receptor pharmacology, hormone signaling, and analytical characterization.

Its defined sequence and molecular identity make Glucagon suitable for GCGR-related research, peptide hormone studies, cAMP signaling assays, HPLC analysis, and MS / LC-MS characterization.

Shandong Juntai Pharmaceutical supports B2B research projects involving Glucagon, related peptide hormones, and customized peptide sequences.

Product Information

Item	Information
Product Name	Glucagon
Alternative Name	Glucagon (1-29)
CAS No.	16941-32-5
Molecular Formula	C153H225N43O49S
Molecular Weight	3482.75 g/mol
Peptide Length	29 amino acids
One-Letter Sequence	HSQGTFTSDYSKYLDSRRAQDFVQWLMNT
Product Type	Peptide Hormone
Research Target	Glucagon Receptor (GCGR)
Category	Peptide Hormones & Analogs
Typical Appearance	White to off-white powder / lyophilized powder
Typical Purity	≥95% by HPLC, reference specification
Storage	Sealed and protected from moisture; low-temperature storage recommended
Intended Use	Research and development use only

Amino Acid Sequence

His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr

Product Features

Defined 29-Amino-Acid Sequence

Glucagon has a clearly defined 29-amino-acid sequence and molecular identity, providing a reliable basis for peptide research and analytical method development.

For research applications, product identity can be assessed through multiple parameters, including sequence information, molecular weight, HPLC profile, and MS / LC-MS data.

Direct Relevance to GCGR Research

Glucagon is a key peptide ligand for the Glucagon Receptor (GCGR), giving it a clear role in receptor-focused research rather than serving only as a general research peptide.

Common research areas include:

• Glucagon receptor interaction
• GCGR signaling
• Receptor pharmacology
• Peptide hormone signaling
• Peptide–receptor interaction studies

Suitable for Multi-Parameter Peptide Characterization

For a 29-amino-acid peptide hormone, analytical evaluation commonly goes beyond a single HPLC purity value.

Depending on project requirements, characterization may include:

• HPLC purity
• Molecular-weight verification
• MS / LC-MS identity
• Sequence confirmation
• Related impurity analysis
• Analytical method performance

The ≥95% HPLC value shown on this page is a common research-grade reference specification. Actual supply specifications should be confirmed according to batch-specific documentation.

Research Applications

Glucagon Receptor (GCGR) Research

Glucagon can be used in studies involving GCGR binding, receptor activation, receptor pharmacology, and downstream signaling mechanisms.

Experimental findings should be interpreted within the specific assay system, model, and research conditions used.

Peptide Hormone and Receptor Interaction Studies

As a defined peptide hormone, Glucagon may support research involving:

• Peptide–receptor interactions
• Hormone–receptor signaling
• Receptor pharmacology
• Peptide structure–function relationships
• Class B GPCR-related studies

cAMP and Cellular Signaling Research

GCGR belongs to a GPCR signaling system, making Glucagon relevant to studies involving GCGR-mediated signaling and cAMP response.

These applications may be combined with cell-based models, receptor-expression systems, and quantitative assay methods.

Analytical and Structural Characterization

Glucagon is also suitable for peptide analysis and analytical development, including:

• HPLC purity analysis
• MS / LC-MS identity confirmation
• Molecular-weight verification
• Peptide characterization
• Related impurity analysis
• Analytical method development

Custom Support

Glucagon-related peptides and other peptide hormone projects can be evaluated according to the requested sequence and technical requirements.

Project discussions may include:

• Glucagon-related sequences
• Peptide hormone projects
• Sequence truncation or extension
• Site-specific amino-acid substitutions
• N-terminal or C-terminal modifications
• Target purity requirements
• HPLC / MS / LC-MS analysis
• Project-specific quantities and packaging

Feasibility is evaluated according to sequence design, purity target, order quantity, and analytical requirements.

Frequently Asked Questions

Can batch-specific COA, HPLC, or MS / LC-MS documentation be provided?

Relevant analytical documentation can be reviewed according to the actual supply batch. If your project requires specific COA, HPLC, MS / LC-MS, or identity data, please include these requirements in your inquiry.

What is the MOQ for Glucagon?

MOQ depends on the requested purity, quantity, packaging format, and current supply arrangement. Small-scale research requirements and larger project quantities can be discussed separately.

Can both small R&D quantities and larger project orders be supported?

Yes. Supply arrangements can be evaluated according to the project stage, target quantity, specification, and analytical requirements.

Can project-specific purity or additional analytical specifications be requested?

Yes. Requirements involving target purity, HPLC, MS / LC-MS, related impurities, or other analytical criteria can be reviewed on a project basis.

How can batch-to-batch consistency be evaluated?

Batch consistency can be assessed using sequence identity, HPLC data, MS / LC-MS results, and batch-specific COA information. For ongoing projects, analytical requirements can be discussed in advance.

Can Glucagon analogs or related peptide sequences be customized?

Yes. Glucagon-related peptides, sequence variants, terminal modifications, and other peptide hormone projects can be evaluated according to the target structure and analytical requirements.

For research and development use only.